Suzuki, J.; Kaji, K.; Nishimura, N.; Kubo, T.; Tomooka, F.; Shibamoto, A.; Iwai, S.; Tsuji, Y.; Fujinaga, Y.; Kitagawa, K.;
et al. A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation. Biomedicines 2023, 11, 1295.
https://doi.org/10.3390/biomedicines11051295
AMA Style
Suzuki J, Kaji K, Nishimura N, Kubo T, Tomooka F, Shibamoto A, Iwai S, Tsuji Y, Fujinaga Y, Kitagawa K,
et al. A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation. Biomedicines. 2023; 11(5):1295.
https://doi.org/10.3390/biomedicines11051295
Chicago/Turabian Style
Suzuki, Junya, Kosuke Kaji, Norihisa Nishimura, Takahiro Kubo, Fumimasa Tomooka, Akihiko Shibamoto, Satoshi Iwai, Yuki Tsuji, Yukihisa Fujinaga, Koh Kitagawa,
and et al. 2023. "A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation" Biomedicines 11, no. 5: 1295.
https://doi.org/10.3390/biomedicines11051295
APA Style
Suzuki, J., Kaji, K., Nishimura, N., Kubo, T., Tomooka, F., Shibamoto, A., Iwai, S., Tsuji, Y., Fujinaga, Y., Kitagawa, K., Namisaki, T., Akahane, T., & Yoshiji, H.
(2023). A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation. Biomedicines, 11(5), 1295.
https://doi.org/10.3390/biomedicines11051295
